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Abstract
Background: Brief screening instruments for co-morbid personality disorders could potentially
have great value in substance abuse treatment settings.
Methods: We assessed the psychometric properties of the 8-item Standardised Assessment of
Personality – Abbreviated Scale (SAPAS) in a sample of 58 methadone maintenance patients.
Results: Internal consistency was modest, but similar to the original value (alpha = 0.62), and test-
retest correlation at four months follow-up was moderately encouraging for a short instrument
such as this (n = 31, test retest intraclass correlation = 0.58), and change at the mean level was
minimal, but marginally significant (from an average of 3.3 to 3.8, p = 0.06). Analyses of nurse ratings
of patients' behaviour at the clinic showed that SAPAS was significantly correlated with nurse
ratings of externalizing behaviour (r = 0.42, p = 0.001), and Global Assessment of Functioning (r =
-0.36, p = 0.006), but unrelated to intoxication (r = 0.02, NS), or withdrawal (r = 0.20, NS).
Conclusion: There is evidence that the SAPAS is a modestly valid and relatively reliable brief
screening measure of personality disorders in patients with ongoing substance abuse undergoing
methadone maintenance. It can be used in situations where limited resources are available, and
researchers or others wish to get an impression of the degree of personality pathology in a clinical
population, as well as for screening purposes.
Background
Personality disorders are among the most common co-
morbidities among patients with substance use disorders
[1,2]. Personality disorders complicate treatment in a
range of ways, elicit negative emotional reactions in clini-
cians [3], and are associated with worse outcome in treat-
ment for substance use disorders [4-7]. Evidence is
emerging that substance abuse treatment is more effective,
if it addresses personality related issues, including person-
ality disorders [8-10].
However, identifying patients with co-morbid personality
disorders remain a challenge for substance abuse treat-
ment services. Self-report inventories tend to diagnose
nearly all substance abusers with personality disorders
[11], and often traits improve rapidly with time [12,13].
Diagnostic interviews are time-consuming, and require
substantial training, and are therefore expensive for serv-
ice providers to carry out. Reducing the number of
patients who need a full personality disorder examination
by screening out patients without personality disorders
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cient and valid measures of personality disorder have not
been validated for substance abusing populations.
Only three interviewer-administered screens for personal-
ity disorder have been published. Langbehn and col-
leagues [14] have developed the Iowa Personality
Disorder Screen (IPDS) to provide a mini-structured inter-
view that the authors estimate can be completed in five
minutes. The IPDS consists of eleven questions that
address general personality disorder criteria as well as spe-
cific criteria. The instrument has been validated against
the Structured Interview for DSM-IV Personality Disorders
(SIDP-IV). The authors reported excellent sensitivity
(92%) and good specificity (79%), although the valida-
tion was a somewhat circular exercise, as the IPDS items
were derived from the SIDP-R. A structured patient inter-
view for personality disorders, the Rapid Personality
Assessment Schedule, requires staff training and performs
moderately well as a screen for personality disorder when
compared to the full version of the PAS (sensitivity = 64%,
specificity = 82%) [15]. Moran and colleagues developed
the Standardised Assessment of Personality, Abbreviated
Scale (SAPAS), a brief interviewer-administered screener
that could be completed in less than 2 minutes, and
reported good sensitivity (0.94) and specificity (0.85) in a
sample of psychiatric patients with a range of different dis-
orders [16].
Such a brief measure could potentially function as a
screener, that is, a brief instrument that could be adminis-
tered in minutes as part of an intake assessment, and
could alert clinicians to the possibility of personality dis-
order, and refer to further assessment. Also, when doing
audits of the prevalence of personality disorders in various
clinical populations, or screening for research studies on
personality disorders, a very brief screener might save
costs.
In this study, we assessed the validity and reliability of the
SAPAS in patients undergoing opioid substitution treat-
ment in a low-threshold setting. We used nurse ratings of
patients' behaviour to indicate the concurrent validity of
the SAPAS scores. Given that problems with behavioural
inhibition, emotional problems, and problems control-
ling substance use characterize personality disorders, we
chose to use observations of the patients' behaviour at
medication pick-up as validation of the instruments.
Methods
Setting
The setting was a public opioid substitution clinic in the
City of Copenhagen. The clinic is one of four clinics pro-
viding free substitution treatment for all opioid depend-
ent patients, who are referred for opioid substitution
treatment within the clinics uptake area. The staff at the
clinic are social workers, physicians, nurses, healthcare
assistant, psychologist, and administrative staff. No
requirement is made that patients abstain from other drug
or alcohol use during treatment, but attempts are made to
help patients stabilize drug and alcohol problems during
treatment.
Patients who are violent or threatening to an extent that is
not manageable within the clinic are referred to a special
opioid substitution bus run by a private company. Thus,
patients are practically never discharged from treatment or
detoxified against their wish. Pharmacotherapy works
with flexible and individualized dosing in close collabora-
tion between physician and patient. There is no official
maximum dose of methadone or buprenorphine,
although generally physicians try to keep doses under 150
millilitres per day. All treatment is free, and is available for
patients with legal residence in Denmark who either live
in the City of Copenhagen, or are homeless and mainly
stay in the Copenhagen area. Tapering of medication is
only carried out on patient demand, and is generally nei-
ther encouraged nor discouraged. Caseworkers are
assigned to clients, and provide counselling and typical
case management services (e.g., assessment of problems
and needs, planning and setting goals, linking with other
services, advocating the patients case with external part-
ners), but are not responsible for monitoring patients'
progress, as patients are expected to come for help when
they need it.
Patients are offered access to drop-in centres that are
placed in various areas of Copenhagen, but no drop-in
centre or café is available at the clinics.
Nurses at the Inner City centre do health check-ups with
patients, during which they assess needs for medical treat-
ment, plan for treatment, contraception, hepatitis testing,
HIV-testing, hepatitis immunization, and the clinic physi-
cian can refer patients to testing or treatment at commu-
nity hospitals.
Procedures
Patients were approached in the clinic by the first author,
and asked whether they were willing to consider partici-
pating in a research study concerning their treatment. Fol-
lowing this, they were given written and verbal
information about the purposes of the study. The main
purpose of the study was a quasi-experimental study of
teaching knowledge about personality disorders to case-
workers. A secondary purpose was to test psychometric
properties of instruments. At follow-up, patients were fol-
lowed up by in-person (n = 29) or telephone interviews (n
= 2). Different interviewers at both points interviewed aPage 2 of 6
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8 patients.
At the follow-up interview, approximately 4 months after
the first assessment, patients were again administered the
SAPAS (see below). When the SAPAS was administered
the second time, patients were instructed not to try to
remember what they had said the first time, and were told
that we wanted to know "if people see themselves in the
same way at two different points in time".
Measures
At baseline, patients were administered a very brief 5
minute interview.
The Standardised Assessment of Personality – Abbreviated Scale 
(SAPAS)
The SAPAS is a brief interview-based screening instrument
consisting of eight dichotomously rated items taken from
the opening section of an informant-based interview, the
Standardised Assessment of Personality, and has been
found to have high sensitivity and specificity as a screener
for personality disorders [16]. The items are listed in Table
1.
Nurse ratings of patient functioning
Nurses rated patients on medication pick-ups using four
rating scales developed for the study. The four rating scales
represented intoxication (0–4, with 0 representing no
intoxication and 4 severe intoxication), withdrawal (0–4,
with 0 representing no withdrawal and 4 severe with-
drawal), externalizing behaviour (0–4, with 0 represent-
ing being polite and friendly and 4 severe aggressiveness),
and global assessment of functioning (GAF, 0–100, with
0 representing the extremely psychiatrically ill patient,
and 100 the extremely psychiatrically healthy person
(adapted from Bodlund [17]). All rating scales contained
anchor points.
We tested inter-rater agreement by having a different rater
rate all patients who came to pick up medication on one
day (n = 26). Inter-rater agreement was satisfactory for sin-
gle item instruments (range for intra-class correlation:
0.39 to 0.53). We also had the treating physician at the
clinic rate a total of 26 patients using the clinical global
impression scale for substance use problems and external-
izing behaviour, and rate the GAF, whilst being blind to
the nurses ratings. Analyses showed moderate associa-
tions between physician ratings and nurses ratings (clini-
cal global impression of current substance use problems
strongly associated with nurse-rated withdrawal and
intoxication: rho = 0.48 and 0.59, p < 0.02; clinical global
impression of externalizing behaviour strongly related
with nurse-rated externalizing behaviours: rho = 0.41, p =
0.04; physician rated GAF strongly related with nurse
rated GAF: rho = 0.62, p < 0.001)).
While the nurses' knowledge of patients varied, they had
health check-ups with patients, and regular contact and
did some case management with patients, especially in
relationship to patients' medical needs.
The nurses and other staff members were kept blind to the
results of the SAPAS and other data from the interviews. A
total of 5 different nurses rated the patients. As pick-up
frequency varied from five days per week to once per two
weeks, the number of ratings differed substantially
between patients.
Sample description
A total of 67 patients were approached, and 87% (58)
gave consent to participate in the study. Seven declined,
and 2 were deemed unable to give consent due to a mix-
ture of language problems and psychiatric problems.
The sample of 58 patients consisted of 42 men and 16
women. The mean age at consent was 39.9 years (SD =
8.97, range = 23 to 62).
Table 1: Reliability of the SAPAS
Four months test-retest reliability Internal consistency
Kappa Kappa with different interviewers Item-total correlation Alpha if deleted
N 31 23 58
Difficulty making and keeping friends 0.53 0.47 0.41 0.57
Usually a loner 0.58 0.51 0.31 0.60
Trusts people 0.58 0.53 0.47 0.55
Normally loses temper easily 0.32 0.32 0.27 0.61
Normally impulsive 0.50 0.58 0.20 0.63
Normally a worrier 0.26 0.25 0.30 0.60
Normally dependent 0.32 0.27 0.35 0.59
Perfectionist 0.50 0.57 0.29 0.61Page 3 of 6
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done maintenance treatment, and 10 were in Buprenor-
phine maintenance treatment. Two accepted participation
in the study, but were unwilling to be interviewed. Poly-
pharmacy was common in the clinic, with 42% receiving
benzodiazepines, 22% receiving antidepressants, and 7%
receiving antipsychotics. In total, 65% received other
medications than opioid substitution. Methadone-doses
were 0–40 mg for 3 patients, 41–80 for 13, and over 80
mg for 32.
Patients were asked about their desire to leave opioid sub-
stitution maintenance. No desire to quit substitution
treatment was reported by 28%, desire to do so some day
in an unknown future by 34%, desire to do so within the
next 6 months by 26%, and desire to quit substitution as
soon as possible by 7%.
A total of 58% had a personality disorder diagnosis
according to the SAPAS [16]. However, the SAPAS does
not show which personality disorder patients have, and
no further assessment of this question was made. The
mean proportion of time since the age of 15 that patients
reported having worked was 26%. Only two patients were
employed at the time of interview.
Analyses
The reliability of the SAPAS was estimated using Cron-
bach's alpha, and test-retest reliability of the full scale was
estimated using intra-class correlation. For each item, we
calculated Cohen's κ as a chance-corrected measure of
agreement.
Criterion validity of the SAPAS was estimated using staff
ratings of functioning, including withdrawal, intoxica-
tion, externalizing behaviour and GAF. We used the mean
of all scores over all observations in a 6-month period at
the clinic to assess validity. We calculated regular Spear-
man correlation coefficients, because there were strong
deviations from normality in the rating scales (externaliz-
ing behaviour and withdrawal had very strong skew.
Results
Reliability of the SAPAS
The results of the reliability analyses are shown in Table 1.
The internal consistency of the SAPAS was slightly lower
in this sample than in the psychiatric sample (α = 0.62).
As in the original study by Moran and colleagues, the
impulsivity item reduced reliability slightly. The test-retest
reliability of individual items ranged from 0.26 to 0.58.
When omitting subjects who were re-interviewed by the
same interviewer at both points, the test-retest reliability
was slightly decreased for 6 of eight items. For the total
SAPAS, the test-retest intraclass correlation was 0.58
(asymptotic z = 2.81, p = 0.005). When omitting subjects
who were interviewed by the same interviewer, the intrac-
lass correlation was reduced to 0.52 (asymptotic z = 2.19,
p = 0.02).
The mean SAPAS score increased from baseline to follow-
up. The mean at baseline was 3.3 (standard deviation =
2.0), and the mean at follow-up was 3.8 (standard devia-
tion = 1.7). The increase was marginally significant (t = -
1.99, p = 0.06).
Criterion validity of the SAPAS
In order to assess the validity of the SAPAS, we used the
nurse ratings of functioning. As pick-up frequency varied
between individuals, the number of ratings that could be
included varied from four to 48 with a mean of 20.1.
The convergent validity correlations are shown in Table 2.
The correlations with withdrawal and intoxication were
non-significant, but the correlations with externalizing
behaviour (rho = 0.38, p < 0.01) and Global Assessment
of Functioning (rho = -0.29, p = 0.03) were significant.
For further illustration, the means and standard deviation
of nurse ratings on the four indicators by SAPAS score are
shown in Table 3. The mean score on externalizing behav-
iour is 0.0 for the single patient scoring 0 on the SAPAS,
but it is clear that the mean score increases as the number
of SAPAS items endorsed increase. Similarly, the GAF
score of patients scoring <3 on the SAPAS are around 60,
but if the score is 6–7, the GAF score is around four points
lower (55–56).
We conducted a multiple regression analysis to control for
age and gender, after rank-order transforming the rating
scales. The results were similar: Externalizing behaviour
(beta = 0.37, t(52) = 2.94, p = 0.004), and GAF (beta = -
0.29, t = 2.19, p = 0.03) remained significantly associated
with SAPAS.
As the number of observations differed due to variability
in pick-up frequency, we also conducted regression analy-
ses controlling for the number of observations that had
been recorded in the clinic. Again, the results were highly
similar: again, externalizing behaviour (beta = 0.43, t(53)
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= 0.01) remained substantially correlated with SAPAS
score.
Other correlates of the SAPAS
No gender difference was found on the SAPAS (men
mean: 3.1, SD = 1.9; women mean: 3.7, SD = 2.3, t(54) =
-0.99, p = 0.33), and the correlation between age and
SAPAS was non-significant (Pearson r = 0.13, NS). Also,
no difference was found between patients who were
receiving methadone substitution and patients who were
receiving buprenorphine substitution (methadone: 2.28,
SD = 2.1; buprenorphine: 3.2, SD = 1.7; t = 0.07, p = 0.94),
and no association was found between methadone dose
and SAPAS score among those in methadone mainte-
nance treatment (r = 0.11, p = 0.46, n = 46).
Total SAPAS score was negatively correlated with the pro-
portion of time since age 15 that had been spent working
without interruption (Spearman rho = -0.31, p = 0.02),
but unrelated to degree of desire to quit methadone
(Spearman rho = -0.07, p = 0.60).
Discussion
The findings of this study supported the validity of the
SAPAS, and gave indications of modest longer-term stabil-
ity. Even when different interviewers interviewed the same
patients 4 months ago, the stability coefficient was rea-
sonable for such a short measure.
Patients who reported more features of personality disor-
ders, were rated as displaying more externalizing behav-
iour was observed by the nurses (unsatisfied,
complaining, angry), and as having lower scores on the
Global Assessment of Functioning. In contrast with our
expectations, we found no strong indication of higher
ongoing substance use during treatment with personality
disorders. However, in this clinic, most patients use drugs
and alcohol to some extent, and stable abstinence is rare.
We did not use another interview or self-report inventory
to assess the validity of the SAPAS. Obviously, this means
that we do not know how many of these patients would
have been diagnosed with another instrument. Although
such a replication of the original findings of Moran and
colleagues could potentially be important, this study adds
new light to the validity of this very brief instrument: the
SAPAS identifies patients with problems that are highly
indicative of personality disorder. It identifies patients
who show more aggressive behaviour, and who appear to
be functioning less well in terms of their mental health.
The SAPAS was constructed based on primary care
patients, and its applicability was originally tested on psy-
chiatric patients [16]. Its items includes item that reflect
content related primarily to cluster A personality (being a
loner), one item relating to both cluster A and B (trusts
people, reversed scored), two items relating to cluster B
disorders (impulsive and problems controlling temper),
and four items relating primarily to cluster C disorders
(difficulty getting and keeping friends; usually dependent;
usually a worrier; perfectionist), and thus has a reasonably
broad coverage of the various personality disorders in the
DSM-IV.
In terms of clinical use, the SAPAS may alert clinicians to
the possibility of personality disorder in a patient, but will
obviously never serve as a substitute for a full assessment
of personality disorders.
Several strengths and limitations deserve comment
The first strength of the study is validation through inde-
pendent and blinded assessment by multiple observers
over an extended period of time, in that several different
Table 3: Nurse ratings by SAPAS scores
Scores on the SAPAS Withdrawal Intoxication Externalizing behaviour Global Assessment of Functioning
N Mean SD Mean SD Mean SD Mean SD
0 1 0.00 0.00 0.00 0.00 0.00 0.00 65.00 0.00
1 13 0.28 0.18 0.71 0.39 0.12 0.12 60.32 3.97
2 10 0.20 0.11 0.80 0.58 0.09 0.10 61.05 3.97
3 8 0.35 0.23 0.78 0.60 0.15 0.17 60.69 6.62
4 9 0.20 0.11 0.50 0.38 0.17 0.15 60.32 2.37
5 6 0.24 0.21 0.65 0.39 0.18 0.18 58.84 5.34
6 3 0.50 0.04 1.05 0.75 0.25 0.29 55.85 7.44
7 6 0.45 0.25 0.64 0.32 0.36 0.23 56.61 5.70
Total 56 0.28 0.19 0.69 0.47 0.16 0.17 59.79 4.80
Notes: SD: Standard deviation.Page 5 of 6
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pick up medications. Patients may fluctuate from day to
day, from week to week, depending on events that occur
in their life, and nurses may differ in their views of partic-
ular patients. However, when observations are averaged
over several observers and several occasions over a long
period of time, these sources of error is levelled out.
Limitations include a limited sample size, and the use of
a cross-sectional sample, rather than a consecutive sam-
ple. Also, the validity correlations are likely to be attenu-
ated as a result of the relative unreliability of the SAPAS.
Conclusion
In conclusion, there is evidence that this very brief meas-
ure gives some indication of the presence of personality
disorder. It may be useful as an indicator of the presence
of personality disorder, either for screening purposes in a
clinical setting, or as a tool in a survey.
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